RLMD
Relmada Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD6.98
+0.29 (+4.33%)
Rating:C-
Company Profile
CEO
Sergio Traversa
IPO Date
2014-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$6.61
Prev. Close
$6.69
Day Low
$6.50
Day High
$7.04
52W Low
$0.55
52W High
$8.00
Market Cap
$0.73B
Volume
2.28M